Atrial Fibrillation History Feature vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Kestra Medical Technologies

AI Verdict

Tool A offers retrospective AFib burden estimation and lifestyle insights for diagnosed individuals, functioning primarily as a personal health management tool. In contrast, Tool B provides continuous ECG monitoring and advanced detection capabilities for at-risk cardiac patients, designed for clinical integration with HIPAA compliance and a remote patient data platform for clinician review.

Choose Atrial Fibrillation History Feature if…

Choose the Atrial Fibrillation History Feature if you are a diagnosed AFib patient seeking retrospective insights into your condition. This tool is ideal for understanding long-term AFib burden trends and how lifestyle factors may influence your heart health, providing data to share with your physician for informed discussions.

View Atrial Fibrillation History Feature →

Choose ASSURE Wearable ECG if…

Choose the ASSURE Wearable ECG if you are an at-risk cardiac patient requiring continuous, proactive heart rate and ECG monitoring. This device is best suited for situations where automatic episode detection, alert-based notifications, and a dedicated platform for clinician review are crucial for managing your cardiac health.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Atrial Fibrillation History Feature ASSURE Wearable ECG
Pricing Unknown Contact for pricing.
Deployment Mobile App Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available No AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA No AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Atrial Fibrillation History Feature

Tool A leverages the widely adopted Apple Watch and Health app, providing a familiar and intuitive user experience for many. Tool B, while designed for comfort with its SensorFit Garment, is a dedicated medical device that requires specific adoption and training by a patient service representative.

Clinical Value

ASSURE Wearable ECG

Tool B offers continuous heart rate monitoring with advanced detection algorithms and alert-based notifications, providing more immediate and comprehensive diagnostic data for clinicians. Tool A provides retrospective AFib burden estimates and lifestyle insights, which are valuable for long-term management but not for real-time event detection.

Pricing & Value

Atrial Fibrillation History Feature

Tool A's AFib History feature is included with a compatible Apple Watch, offering significant incremental value to users who already own the hardware. Tool B requires contacting the company for pricing, indicating a dedicated medical device cost that is likely higher and less transparent.

Enterprise Readiness

ASSURE Wearable ECG

Tool B explicitly states HIPAA compliance and having a Business Associate Agreement (BAA), along with a cloud-based remote patient data platform (Kestra CareStation) for clinician review. This makes it suitable for integration into healthcare enterprise workflows, unlike Tool A which is a consumer-focused feature.

Innovation

ASSURE Wearable ECG

Tool B demonstrates more specialized technological innovation with its SensorFit Garment, Quad Channel Processing, and Adaptive Patient Intelligence for robust continuous ECG monitoring and artifact filtering. Tool A's innovation is primarily in making retrospective AFib insights accessible and integrated into a widely used consumer device.

Support & Docs

Tie

Both tools offer robust support and documentation tailored to their respective user bases. Apple provides extensive consumer-facing support for its products, including the AFib History feature, while Kestra Medical Technologies offers specialized support and resources for patients and clinicians using a medical device.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Atrial Fibrillation History Feature ASSURE Wearable ECG
Product Name Atrial Fibrillation History Feature ASSURE Wearable ECG
Company Apple Kestra Medical Technologies
Primary Function Provides diagnosed users with retrospective estimates of AFib burden and insights into how lifestyle factors may influence their condition. Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients.
Clinician Data Access/Review PDF export of AFib History data for sharing with healthcare providers. Kestra CareStation remote patient data platform for clinician review.
Monitoring Type Retrospective AFib burden estimation (weekly percentage); Not intended for real-time AFib detection or continuous monitoring. Continuous heart rate monitoring via wearable ECG device.
Activation Requirement Requires a prior physician diagnosis of AFib for activation. Not specified

Videos

Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A is intended for users aged 22 years and over who have a prior physician diagnosis of AFib, providing retrospective estimates of AFib burden. Tool B is designed for continuous heart rate monitoring and data collection in at-risk cardiac patients, particularly those who have completed use of a Wearable Cardioverter Defibrillator (WCD) and require continued monitoring.
Tool A offers retrospective estimates of AFib burden and trends over time, and is not intended for real-time AFib detection or continuous monitoring. Tool B provides continuous heart rate monitoring with automatic episode storage and alert-based notifications.
With Tool A, patients can export their AFib History data as a PDF for sharing with healthcare providers, or share it automatically with enrolled providers in the United States. Tool B integrates with the Kestra CareStation remote patient data platform for clinician review, offering clear patient reports and configurable notifications.
Tool A requires a prior physician diagnosis of AFib for activation, and the patient must be 22 years of age or older. Tool B is intended for patients who have been prescribed the device by their physician, and a Kestra patient service representative fits and trains the patient on its proper use.
Tool A provides weekly retrospective AFib burden estimates and visualizations of how lifestyle factors (sleep, activity, alcohol, weight, mindful minutes) may impact AFib. Tool B offers continuous heart rate monitoring, automatic episode storage, alert-based notifications, and physiologic trend data, including detection of VT, VF, bradycardia, asystole, and non-sustained ventricular arrhythmia episodes.

Backers

Who funded each tool's parent company.

Atrial Fibrillation History Feature

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.